Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...

Full Year 2024 Results Key Financial Results Revenue: US$610.8m (down 1.3% from FY ...

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Air T Inc (AIRT) is expected to report for 3Q. American Axle & Manufacturing Holdings Inc (AXL) is expected to report $-0.15 for 4Q. Astrotech Corp (ASTC) is expected to report for 2Q.

Spotify Technology S.A. 1.21% $128.62B ...

AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D 0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C) 0.31% AGNC Investment Corp ...

We read all day so you don't have to. Sign up for CNN Business' newsletter for the top stories you need to know.